Physician profile
David P Coll
NPI 1104835479
$1,351.46
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $176 · 2021: $135 · 2022: $47.30 · 2023: $148 · 2024: $204 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $570.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $316.01 | 2021-2025 | Abre, Turbohawk, Endurant Iis |
| Smith+Nephew, INC. | $157.08 | 2019-2023 | Collagenase Santyl |
| Boston Scientific Corporation | $154.40 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $153.53 | 2020-2023 | Xarelto |
| W. L. Gore & Associates, INC. | $134.79 | 2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Keswick Pharmaceuticals LLC | $113.79 | 2019 | |
| Organogenesis INC. | $85.37 | 2019 | |
| Ethicon US, LLC | $52.10 | 2021 | |
| Medtronic Vascular, INC. | $37.45 | 2020 | |
| Cook Medical LLC | $32.03 | 2023 | Advance |
| Philips North America LLC | $27.76 | 2021-2022 | |
| Kerecis Limited | $19.94 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| E.R. Squibb & Sons, L.L.C. | $19.92 | 2024 | Eliquis |
| Pfizer INC. | $17.33 | 2023 | |
| Aroa Biosurgery Incorporated | $17.07 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12.89 | 2023 | Teflaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Coll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.